Document is current
Any future updates will be listed below
-
Authors
Kim, Jiyeong
Pacheco, Juan Pablo Gonzalez
Golden, Ashleigh
Aboujaoude, Elias
van Roessel, Peter
Gandhi, Aayushi
Mukunda, Pavithra
Avanesyan, Tatevik
Xue, Haopeng
Adeli, Ehsan
Kim, Jane Paik
Saggar, Manish
Stirman, Shannon Wiltsey
Kuhn, Eric
Supekar, Kaustubh
Pohl, Kilian M.
Rodriguez, Carolyn I.
-
Funding
Funding for this research was provided by:
National Institutes of Health (K01MH137386, LM014597, R01MH133553)
- License Information
-
More Information
Article History
Accepted: 24 April 2025
First Online: 14 June 2025
Declarations
:
: J.K is supported by NIH Grant (K01MH137386). In the last 3 years, C.I.R. has served as a consultant for Biohaven Pharmaceuticals, Osmind, and Biogen; and receives research grant support from Biohaven Pharmaceuticals, a stipend from American Psychiatric Association Publishing for her role as Deputy Editor at The American Journal of Psychiatry, a stipend from Springer Nature for her role as Deputy Editor for Neuropsychopharmacology, and book royalties from American Psychiatric Association Publishing. C.I.R. is supported in part by NIMH grant (R01MH133553). A.G. currently provides professional services to Wayhaven and Augmend Health, holds equity in Storymine Inc., Woebot Health, and Lark Health, and previously served as a consultant to ChatOwl. E.A. is an advisor to Limbix Health and board member of MediKarma. K.S is supported by NIH Grant (LM014597, AG072114). The remaining authors declare no competing financial or non-financial interests or other relationships relevant to the subject of this manuscript.
